1. Home
  2. IMUX vs GAIA Comparison

IMUX vs GAIA Comparison

Compare IMUX & GAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMUX
  • GAIA
  • Stock Information
  • Founded
  • IMUX 2016
  • GAIA 1988
  • Country
  • IMUX United States
  • GAIA United States
  • Employees
  • IMUX N/A
  • GAIA N/A
  • Industry
  • IMUX Biotechnology: Pharmaceutical Preparations
  • GAIA Movies/Entertainment
  • Sector
  • IMUX Health Care
  • GAIA Consumer Discretionary
  • Exchange
  • IMUX Nasdaq
  • GAIA Nasdaq
  • Market Cap
  • IMUX 92.2M
  • GAIA 105.7M
  • IPO Year
  • IMUX N/A
  • GAIA 1999
  • Fundamental
  • Price
  • IMUX $0.76
  • GAIA $4.01
  • Analyst Decision
  • IMUX Strong Buy
  • GAIA Strong Buy
  • Analyst Count
  • IMUX 5
  • GAIA 1
  • Target Price
  • IMUX $6.00
  • GAIA $9.00
  • AVG Volume (30 Days)
  • IMUX 1.3M
  • GAIA 41.8K
  • Earning Date
  • IMUX 11-13-2025
  • GAIA 11-03-2025
  • Dividend Yield
  • IMUX N/A
  • GAIA N/A
  • EPS Growth
  • IMUX N/A
  • GAIA N/A
  • EPS
  • IMUX N/A
  • GAIA N/A
  • Revenue
  • IMUX N/A
  • GAIA $98,622,000.00
  • Revenue This Year
  • IMUX N/A
  • GAIA $13.81
  • Revenue Next Year
  • IMUX N/A
  • GAIA $15.74
  • P/E Ratio
  • IMUX N/A
  • GAIA N/A
  • Revenue Growth
  • IMUX N/A
  • GAIA 14.80
  • 52 Week Low
  • IMUX $0.56
  • GAIA $2.93
  • 52 Week High
  • IMUX $1.42
  • GAIA $6.53
  • Technical
  • Relative Strength Index (RSI)
  • IMUX 47.49
  • GAIA 29.43
  • Support Level
  • IMUX $0.67
  • GAIA $4.07
  • Resistance Level
  • IMUX $0.79
  • GAIA $4.48
  • Average True Range (ATR)
  • IMUX 0.05
  • GAIA 0.27
  • MACD
  • IMUX 0.00
  • GAIA -0.06
  • Stochastic Oscillator
  • IMUX 64.28
  • GAIA 13.71

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

About GAIA Gaia Inc.

Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. Geographically, it derives a majority of its revenue from the United States and also has an International presence.

Share on Social Networks: